Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- Experts Talk over Biosimilar Challenges, Chide Unstable Supplies and Indication Gaps
July 19, 2019
- OTC Groups Call for Enhancing Self-Medication Tax Break, Submit Request
July 19, 2019
- Towards 2020 Reform, JPMA Wants Its Three-Pronged Proposal to Resonate with Public
July 17, 2019
- FPMAJ Asks Member Drug Makers to Conduct Self-Inspections to Ensure Stable Supplies
July 11, 2019
- Generic Association Aims to Contribute to Pre-Symptomatic and Preventive Care: New Industry Vision
July 9, 2019
- JPMA Pushing Teleworking for Member Companies
July 5, 2019
- Generic Use Rate at 74.0% in FY2018: JGA
July 1, 2019
- Govt’s 2019 Honebuto Policy Generally in Line with JPMA Views: President
June 28, 2019
- Revisit Comparator Selection Criteria for New Drug Pricing: JPMA
June 28, 2019
- OTC Group Unveils Reform Requests for Self-Medication Tax Break
June 25, 2019
- Further Pricing Discussions Needed for Pricey Products beyond Kymriah: JMA Chief
June 25, 2019
- Health Insurance Coverage Necessary for Risk Reducing Treatments for BRCA Positive Patients: Cancer Bodies
June 21, 2019
- Japan Doctors’ Lobby Braced for Tough Social Security Debate after Election
June 20, 2019
- Generic Share Hits Plateau after Reaching 70%: FPMAJ Pharmacy Survey
June 17, 2019
- Don’t Expand Comparator PMP Removal Rule, Set Deduction Limit for Method II: FPMAJ
June 17, 2019
- Discuss Cost Effectiveness Assessment, Disclosure Ratios Separately: FPMAJ
June 17, 2019
- FPMAJ Calls for Post-Launch Premiums for Add’l Indications, Evidence
June 17, 2019
- Fix Price Maintenance Premium to Make It Fit Its Concept, Revisit Product/Company Criteria: FPMAJ
June 17, 2019
- JPMA Nudges PMDA to Increase Int’l Staffers, Drive Harmonization in Asia
June 12, 2019
- Doctors’ Lobby Voices Opposition to Changing Health Coverage, Copay Rates for Minor Illnesses
June 6, 2019
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…